Skip to content

Clinical trials

Completed Phase 2/3 Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 2/3 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20091
20101
20111
20151
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Aeris Therapeutics1
Daniels, Craig E., M.D.1
Fudan University1
R-Pharm International, LLC1
US Department of Veterans Affairs1
University of Massachusetts, Worcester1
University of Washington, the Collaborative Health Studies Coordinating Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases9
Respiratory Tract Diseases3
Pathologic Processes2
Pulmonary Disease, Chronic Obstructive2
Respiratory Tract Infections2
Asthma1
Bronchial Diseases1
Bronchitis1
Bronchitis, Chronic1
Bronchopulmonary Dysplasia1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.